Precision Cancer Surgery —
At 1/3 Of US Costs, Without the Wait

We address this honestly in the section above — the gap is real at the national level, but elite-center outcomes tell a different story. Beyond survival rates, three practical factors drive the decision for many patients: cost (self-pay surgery at 60–90% less), speed (5–7 days vs. months on a waiting list), and access (therapies like CAR-T that may be financially out of reach at home). If your cancer is staged and treatable, and your home system would make you wait weeks or months for surgery, the question becomes: does the risk of waiting outweigh the risk of traveling? For many patients, the answer is yes — and that's before considering the savings.

Several independent channels exist: hospital rankings — China's top cancer centers (e.g., Ruijin, Fudan Cancer Center, Sun Yat-Sen) are ranked by Fudan University's annual hospital reputation index, widely considered the most credible ranking in China. Surgeon credentials — we provide each patient's assigned surgeon's academic title, publication record (searchable on PubMed), and representative case volumes before you commit. JCI/CIHA accreditation — many partner hospitals hold international accreditation. Published outcomes — for specific procedures, our hospitals have peer-reviewed publications documenting complication rates and survival data. We encourage you to verify everything independently — and we'll provide the source links to do so.

The 5–7 day timeline is a typical case, not a fixed promise. If your pre-operative workup (imaging, pathology, blood work, cardiac assessment) reveals anything that requires further investigation, the timeline extends — safely. Your surgeon will never proceed until all risk factors are cleared. What makes China efficient isn't skipping steps — it's parallel processing: imaging, lab work, and MDT review happen simultaneously rather than sequentially across multiple appointments. If complications arise during or after surgery, top Chinese hospitals have full ICU capability and 24/7 surgical backup. The speed you see in the timeline above comes from system coordination — not from rushing your care.

Eligibility depends on your cancer type, stage, prior treatments, and overall health. CAR-T therapy, for example, is currently approved for certain hematologic cancers (lymphoma, leukemia, multiple myeloma) — not solid tumors. Clinical trial eligibility is even more specific, often depending on genetic markers and treatment history. The best way to know is to send us your pathology report and treatment history — our MDT team will assess which options are genuinely appropriate for your case. We'll be honest if a therapy isn't suitable: suggesting advanced surgery when immunotherapy isn't indicated, or confirming that an experimental trial isn't the right path. The pricing calculator above shows indicative costs for reference.

No. International patient centers provide dedicated English-speaking coordinators and interpreters — from airport pickup, through every test, MDT consultation, and surgery, to follow-up. You receive bilingual medical records, pathology reports, treatment plans, and discharge summaries. For non-English speakers, interpretation in Russian, Arabic, and Spanish can also be arranged. Many senior surgeons have trained or presented at international conferences in English. Your care team is accessible throughout your journey.

Each international hospital provides detailed remote follow-up instructions and can coordinate with your local oncologist or GP to ensure seamless long-term care. Your surgical team remains accessible for questions via our coordination service. Follow-up imaging and pathology reports can be reviewed remotely. The English surgical reports, pathology results, and treatment summaries we provide are accepted by oncologists worldwide. For patients who need in-person follow-up, we can coordinate any future visits into a return trip. Postoperative remote follow-up support is a standard part of our service.

It depends on the clinic type. Most public hospital international departments do not accept international insurance — payment is typically out-of-pocket at time of service. Many private international clinics and CIHA-certified hospitals, however, do accept direct billing from major global insurers including Cigna, Aetna, Bupa, and Allianz. Contact us before you travel and we'll check which partner clinics are in your insurer's network — and give you an honest, no-pressure comparison of your options. Even self-paying in China is often less than your home deductible.